Genelux

Genelux Current Ratio

The Current Ratio of Genelux (GNLX) as of Oct 18, 2026 is 2.43. In the previous year, Current Ratio was 3.83 — a change of -36.55% (lower).

Current Ratio

2.43

YoY

-36.55%

Last updated:

Current Ratio of Genelux is 2025 2.43 . Current Ratio of Genelux was 2024 3.83 . It decreases by -36.55% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genelux Stock analysis

What does Genelux do? Genelux Corp, trading under the ticker GNLX, is a biotechnology company based in Westlake Village, California, operating within the Health Care sector. The company has 25 employees and completed its initial public offering on January 26, 2023. Genelux focuses on developing oncolytic viral immunotherapies for solid tumor cancers. Its lead product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a modified vaccinia virus (VACV), a stable DNA virus with significant engineering potential. The company is currently advancing Olvi-Vec through Phase II clinical trials for platinum-resistant or refractory ovarian cancer (PRROC). Additionally, Genelux is developing a platform called Virus and Vaccine (Neoantigen)-Enhanced Adoptive Cell Therapy (V2ACT), which aims to enhance cancer neoantigen-specific T cell activity within tumors. The company also has an animal health product candidate, V-VET1, a genetically characterized, veterinary-grade oncolytic vaccinia virus that is a naturally attenuated isolate. Genelux's website is https://genelux.com/ and it is registered with the ISIN US36870H1032. The company's operations and product development are centered on innovative viral-based therapies for both human and animal health applications. Genelux is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genelux stock

Current Ratio of Genelux is 2.43 in 2025.

Current Ratio of Genelux changed from 3.83 to 2.43, representing a -36.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Genelux since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Genelux with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Genelux

All Key Metrics — Genelux